Matches in SemOpenAlex for { <https://semopenalex.org/work/W2158185940> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W2158185940 endingPage "S753" @default.
- W2158185940 startingPage "S752" @default.
- W2158185940 abstract "Specific treatment of obsessive compulsive disorder (OCD) is based on cognitive-behavioral therapy, serotonin reuptake inhibitors (SRIs) or their combination. Treatment strategies do not always follow evidence-based guidelines in outpatient settings. Data on pharmacotherapy in inpatient settings are lacking.Prescription data for inpatients suffering from OCD in the time period 1994–2012 were obtained from the database of the Drug Safety Program in Psychiatry (AMSP). Data were collected on two index dates per year; the prescription patterns and changes over time were analysed.Of 842 patients 89.9% received at least one psychotropic drug and 67.6% a combination of at least two psychotropic drugs. The drug groups prescribed most often were antidepressants (78.0%), antipsychotics (46.7%), and tranquilizers (19.7%). In 58.0% of all cases selective serotonin reuptake inhibitors (SSRIs) were used as antidepressants, followed by tricyclic antidepressants (TCAs, 17.8%), mainly clomipramine (10.9%). Second-generation antipsychotics (SGAs) were administered in 37.8% of all cases, first-generation antipsychotics (FGAs) in 13.7%. While the use over time significantly increased for psychotropic drugs, antidepressants, antipsychotics, tranquilizers, SSRIs and SGAs, it remained stable for FGAs and decreased for TCAs.Observational cross-sectional study without follow-up or additional information.In clinical practice, most OCD patients received pharmacological treatment. The high prescription rate of SSRIs and their preference over clomipramine as well as the augmentation of this therapy with SGAs comply with the guidelines. Administration of tranquilizers as well as sedative FGAs and the choice of single SGAs are not in line with expert recommendations." @default.
- W2158185940 created "2016-06-24" @default.
- W2158185940 creator A5006249474 @default.
- W2158185940 date "2014-10-01" @default.
- W2158185940 modified "2023-09-25" @default.
- W2158185940 title "C.02.01 Efficacy and tolerability of antipsychotic treatment" @default.
- W2158185940 doi "https://doi.org/10.1016/s0924-977x(14)71213-1" @default.
- W2158185940 hasPublicationYear "2014" @default.
- W2158185940 type Work @default.
- W2158185940 sameAs 2158185940 @default.
- W2158185940 citedByCount "0" @default.
- W2158185940 crossrefType "journal-article" @default.
- W2158185940 hasAuthorship W2158185940A5006249474 @default.
- W2158185940 hasConcept C118552586 @default.
- W2158185940 hasConcept C126322002 @default.
- W2158185940 hasConcept C170493617 @default.
- W2158185940 hasConcept C197934379 @default.
- W2158185940 hasConcept C2426938 @default.
- W2158185940 hasConcept C2776412080 @default.
- W2158185940 hasConcept C2778173252 @default.
- W2158185940 hasConcept C2778375690 @default.
- W2158185940 hasConcept C2779305415 @default.
- W2158185940 hasConcept C2780035454 @default.
- W2158185940 hasConcept C2780494398 @default.
- W2158185940 hasConcept C2781081902 @default.
- W2158185940 hasConcept C2993714069 @default.
- W2158185940 hasConcept C500440147 @default.
- W2158185940 hasConcept C71924100 @default.
- W2158185940 hasConcept C98274493 @default.
- W2158185940 hasConceptScore W2158185940C118552586 @default.
- W2158185940 hasConceptScore W2158185940C126322002 @default.
- W2158185940 hasConceptScore W2158185940C170493617 @default.
- W2158185940 hasConceptScore W2158185940C197934379 @default.
- W2158185940 hasConceptScore W2158185940C2426938 @default.
- W2158185940 hasConceptScore W2158185940C2776412080 @default.
- W2158185940 hasConceptScore W2158185940C2778173252 @default.
- W2158185940 hasConceptScore W2158185940C2778375690 @default.
- W2158185940 hasConceptScore W2158185940C2779305415 @default.
- W2158185940 hasConceptScore W2158185940C2780035454 @default.
- W2158185940 hasConceptScore W2158185940C2780494398 @default.
- W2158185940 hasConceptScore W2158185940C2781081902 @default.
- W2158185940 hasConceptScore W2158185940C2993714069 @default.
- W2158185940 hasConceptScore W2158185940C500440147 @default.
- W2158185940 hasConceptScore W2158185940C71924100 @default.
- W2158185940 hasConceptScore W2158185940C98274493 @default.
- W2158185940 hasLocation W21581859401 @default.
- W2158185940 hasOpenAccess W2158185940 @default.
- W2158185940 hasPrimaryLocation W21581859401 @default.
- W2158185940 hasRelatedWork W2040460022 @default.
- W2158185940 hasRelatedWork W2048923990 @default.
- W2158185940 hasRelatedWork W2140974527 @default.
- W2158185940 hasRelatedWork W2158419767 @default.
- W2158185940 hasRelatedWork W2337789234 @default.
- W2158185940 hasRelatedWork W2357949124 @default.
- W2158185940 hasRelatedWork W2364729855 @default.
- W2158185940 hasRelatedWork W2468646945 @default.
- W2158185940 hasRelatedWork W2469819868 @default.
- W2158185940 hasRelatedWork W3010889186 @default.
- W2158185940 hasVolume "24" @default.
- W2158185940 isParatext "false" @default.
- W2158185940 isRetracted "false" @default.
- W2158185940 magId "2158185940" @default.
- W2158185940 workType "article" @default.